Astex Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
- Pages: 35
- Published: August 2017
- Report Code: 28A3BE0C-C774-4AE4-AD1F-5DAE0CDDFF4F
Astex Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
Astex Pharmaceuticals, Inc. (Astex or 'the company'), a subsidiary of Otsuka America, Inc., is engaged in the discovery, development and commercialization of cancer therapies in the US. The company is headquartered in Dublin, California.
Scope
– Detailed information on Astex Pharmaceuticals, Inc. required for business and competitor intelligence needs
– A study of the major internal and external factors affecting Astex Pharmaceuticals, Inc. in the form of a SWOT analysis
– An in-depth view of the business model of Astex Pharmaceuticals, Inc. including a breakdown and examination of key business segments
– Intelligence on Astex Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
– News about Astex Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
– Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Astex Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Astex Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Astex Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.